They used the CRISPR/Cas9-loaded exosomes to suppress the expression of poly (ADP-ribose) polymerase-1 (PARP-1), which was closely related to the repair of chemotherapy-induced DNA damage in cancer cells. The gene discussed is PARP1; the disease is cancer.